> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Amneal Recalls 13 Lorazepam Lots Over Dose Dropper
- URL: https://www.fdaweb.com/amneal-recalls-13-lorazepam-lots-over-dose-dropper/
- Published: 2017-08-16T12:00:00.000Z
- Updated: 2026-09-14T22:41:31.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5139403

Amneal Pharmaceuticals has recalled 13 lots of lorazepam oral concentrate, USP 2mg/mL, due to a defect in the dropper markings. The Lorazepam Oral Concentrate, USP 2mg/mL, product is packaged with a third party-manufactured dosing dropper has been found in some instances to have printed dose markings in reverse number order, no dose markings or dose markings that are shifted, according to a [recall notice](https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm571796.htm?ref=fdaweb.com). To date no adverse events related to dropper defects have been reported. Lorazepam is indicated for the management of anxiety disorders for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms.